Eurazeo encarga a Vaultinum una auditoría cibernética y tecnológica
March 29, 2023 08:30 ET
|
Vaultinum
PARÍS, March 29, 2023 (GLOBE NEWSWIRE) -- Eurazeo ha designado a Vaultinum, empresa suiza especializada en la protección y auditoría de software y otros activos tecnológicos, para auditar el...
Vaultinum wird von Eurazeo mit der Durchführung eines Cyber- und Tech-Audits beauftragt
March 29, 2023 08:30 ET
|
Vaultinum
PARIS, March 29, 2023 (GLOBE NEWSWIRE) -- Eurazeo hat Vaultinum, ein Schweizer Unternehmen, das auf den Schutz und die Prüfung von Software und anderen technologischen Assets spezialisiert ist, mit...
Théa Open Innovation and Galimedix announce strategic partnership to develop and commercialize GAL-101, a Phase 2/3-ready small molecule, to treat ophthalmic indications with high unmet medical need
March 29, 2023 08:00 ET
|
Galimedix Therapeutics, Inc.
Galimedix eligible for upfront payment plus various success-based milestone payments and royalties on future net salesEquity investment by Théa Open Innovation into Galimedix supports further...
(XM): Johnson Fistel Investigates Proposed Sale of Qualtrics International; Is $18.15 a Fair Price?
March 23, 2023 19:33 ET
|
Johnson Fistel, LLP
SAN DIEGO, March 23, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Qualtrics International Inc. (Nasdaq:...
Robex Announces the Signing of the US$ 35 Million Bridge Facility With Taurus
March 21, 2023 13:58 ET
|
Robex Resources Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES QUEBEC CITY, March 21, 2023 (GLOBE NEWSWIRE) -- Robex Resources Inc. (TSXV: RBX; FRA: RB4) (“Robex”...
Catalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA® (Perampanel) CIII
January 25, 2023 08:03 ET
|
Catalyst Pharmaceuticals, Inc.
Strengthens its Commercial Portfolio with the First and Only AMPA Receptor Antagonist Marketed Product for Epilepsy Bolsters Presence in Neuroscience Expected to be Accretive in 2023 ...
CryoMass Signs $10.2 Million Multi-State License Agreement
January 18, 2023 07:10 ET
|
Cryomass Technologies
DENVER, Jan. 18, 2023 (GLOBE NEWSWIRE) -- CryoMass Technologies Inc. (the “Company” or “CryoMass”) (OTCQX: CRYM) is pleased to announce the signing of a multi-state license agreement with...
Catalyst Pharmaceuticals to Acquire U.S. Commercial Rights to FYCOMPA® (Perampanel) CIII From Eisai Co., Ltd
December 19, 2022 16:10 ET
|
Catalyst Pharmaceuticals, Inc.
Acquisition Expands The Company’s Commercial Portfolio With An Established U.S. Marketed Product Company Remains Dedicated To Growth Within Neurology Through Continued Active Business Development...
Black Friday is Around the Corner: Epomaker Hits the Exciting November Hot-Sale Wave for Mechanical Keyboard Enthusiasts
November 25, 2022 08:00 ET
|
Epomaker
NEW YORK, Nov. 25, 2022 (GLOBE NEWSWIRE) -- Epomaker, the professional customizable mechanical keyboards and accessories provider, launches its Hot-Sale Month campaign for the whole of November in...
vTv Therapeutics Announces Investment by CinRx Pharma
July 25, 2022 07:00 ET
|
vTv Therapeutics Inc.
HIGH POINT, N.C., July 25, 2022 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) today announced entry into agreements that include a $10 million investment by CinPax, LLC (“CinPax”), a...